GPT and metabolic dysfunction-associated steatotic liver disease: found in a Mc4r-KO knockout MASH mouse and a LPS-induced MASH mouse model that ADSC intervention significantly reduced the levels of serum ALT and inflammatory markers, while increasing the proportion of anti-inflammatory macrophages in the liver, providing a new basis for the treatment of MASLD (45).